StockGlow

Finch Therapeutics Group, Inc. (FNCHQ)

Develops oral microbiome drugs to treat autism, inflammatory bowel disease, and other conditions.

$9.97-0.00%Healthcare
Compare FNCHQ with
StockGlow Score
46
Neutral
BearishBullish
1 year ago-23.0%

The outlook

FNCHQ is trading near the middle of its 52-week range at $9.97 with a neutral overall score. The stock shows mixed momentum against its moving averages, neither clearly above nor below key technical levels. Analyst coverage appears limited, making consensus views unclear.

What’s behind the score

Price trendMixed vs its moving averages
52-week range57% of the way from its 52-week low to high
Market cap
$16.0M
52-wk high
$16.10
52-wk low
$2.00
50-day avg
$8.87
200-day avg
$11.27
Trailing P/E
—

Similar stocks

CNTBConnect Biopharma Holdings Limited$2.08-0.95%NEXINexImmune, Inc.$0.00+0.00%DSGNDesign Therapeutics, Inc.$11.87-0.08%HOWLWerewolf Therapeutics, Inc.$0.45-0.88%CGEMCullinan Therapeutics, Inc.$17.47+0.23%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy